Research shows that up to 40% of heart surgery patients have low red blood cell counts before their operation, significantly increasing surgical risks. According to Gram Research analysis, doctors now recommend screening patients for anemia weeks before surgery and treating it with iron supplements, vitamins, and other medications. When hospitals use a comprehensive blood management program that includes preoperative anemia treatment, patients experience fewer complications, less bleeding, and faster recovery after heart surgery.

According to Gram Research analysis, up to 40% of patients facing heart surgery have low red blood cell counts before their operation, which can lead to serious complications. Doctors now recommend screening patients for anemia and iron deficiency weeks before surgery and treating these conditions with iron supplements, vitamins, and other medications. This review examines the best ways to identify and fix low blood counts before heart surgery, including which treatments work best, how much to give, and how long they take to work. When hospitals use a complete blood management program that includes these treatments, patients have better outcomes and fewer complications during and after their surgery.

Key Statistics

A 2026 review in Innovations journal found that up to 40% of cardiac surgery patients present with preoperative anemia, a condition associated with significantly increased perioperative risks and complications.

According to a 2026 review of cardiac surgery best practices, comprehensive patient blood management programs that include preoperative anemia screening and treatment reduce surgical complications and improve patient outcomes compared to standard care.

A 2026 clinical review found that intravenous iron replacement, when started 4-6 weeks before heart surgery, can normalize red blood cell counts within 4-6 weeks, reducing the need for blood transfusions during surgery.

The Quick Take

  • What they studied: How doctors should identify and treat low red blood cell counts in patients before they have heart surgery
  • Who participated: This is a review of existing research and best practices; it examines studies involving cardiac surgery patients, up to 40% of whom have anemia before their operation
  • Key finding: Screening for anemia and iron deficiency before heart surgery, then treating these conditions with iron, vitamins, and other medications, significantly reduces surgical risks and improves patient outcomes
  • What it means for you: If you’re scheduled for heart surgery, ask your doctor to check your blood iron and red blood cell levels weeks in advance. If levels are low, treatment before surgery can help you recover better and have fewer complications. Talk to your surgical team about a blood management plan tailored to your needs.

The Research Details

This is a comprehensive review article that examines current best practices for managing low red blood cell counts in heart surgery patients. Rather than conducting a new experiment, the authors analyzed existing research, clinical guidelines, and treatment protocols to summarize what doctors know works best. The review covers multiple treatment approaches including iron supplements given through veins, vitamin B12, folic acid, and medications that stimulate red blood cell production. The authors explain how each treatment works, the right doses to use, and how long patients should expect to wait before seeing improvements in their blood counts.

Heart surgery is physically demanding on the body, and patients with low red blood cell counts face extra risks during and after the operation. Red blood cells carry oxygen throughout your body, so having too few means your heart, brain, and other organs don’t get enough oxygen during surgery. By identifying and treating anemia before surgery, doctors can reduce bleeding complications, the need for blood transfusions, and other serious problems. This review helps surgical teams understand the most effective strategies for preparing anemic patients for heart surgery.

This is a review article written by experts in cardiac surgery, published in a peer-reviewed medical journal. While it doesn’t present new experimental data, it synthesizes existing research and clinical experience to provide evidence-based recommendations. The strength of the recommendations depends on the quality of the underlying studies reviewed. Readers should know this represents current expert consensus on best practices rather than results from a single new study.

What the Results Show

The review confirms that preoperative anemia (low red blood cell counts before surgery) is extremely common in heart surgery patients, affecting up to 40% of those scheduled for procedures. This condition significantly increases the risk of serious complications during and after surgery, including excessive bleeding, the need for blood transfusions, infections, and longer hospital stays. The authors recommend a proactive approach that includes screening all cardiac surgery patients for anemia and iron deficiency at least several weeks before their scheduled operation. Early detection allows time for treatment to work before surgery begins.

The review details specific treatment options and their effectiveness. Intravenous iron (iron given directly into the bloodstream) works faster than oral iron supplements and is preferred for patients with limited time before surgery. Vitamin B12 and folic acid address nutritional deficiencies that contribute to anemia. Erythrocyte stimulating agents are medications that signal the body to produce more red blood cells, though they require careful monitoring. The authors emphasize that combining these treatments within a comprehensive blood management program produces better results than treating anemia in isolation. Hospitals that implement full blood management programs see fewer transfusions, shorter recovery times, and better overall patient outcomes.

This review reflects a shift in cardiac surgery practice toward proactive anemia management. Historically, doctors focused on managing anemia during and after surgery. Current evidence shows that identifying and treating anemia before surgery is more effective and safer. The comprehensive blood management approach described here represents the evolution of surgical best practices based on accumulated clinical evidence. This aligns with guidelines from major surgical organizations that now recommend preoperative screening and treatment as standard care.

As a review article rather than a new research study, this work synthesizes existing evidence but doesn’t provide new experimental data. The effectiveness of treatments may vary depending on individual patient factors, the type of heart surgery planned, and how much time is available before the operation. Some patients may not tolerate certain treatments or may have conditions that prevent their use. The review focuses on cardiac surgery specifically, so findings may not apply to other types of surgery. Implementation of these best practices depends on hospital resources and whether surgical teams have time to treat anemia before the scheduled operation.

The Bottom Line

Strong evidence supports screening all cardiac surgery patients for anemia and iron deficiency at least 4-6 weeks before their scheduled operation. If anemia is detected, treatment with intravenous iron, vitamin B12, folic acid, or red blood cell-stimulating medications should begin immediately. Patients should work with their surgical team to develop a personalized blood management plan. These interventions should be part of a comprehensive hospital program that includes careful blood conservation during surgery and monitoring after the operation.

Anyone scheduled for heart surgery should discuss anemia screening with their surgical team. This is especially important for patients who know they have a history of anemia, iron deficiency, or nutritional problems. Patients over 65, those with chronic kidney disease, and those taking certain medications are at higher risk for anemia. Conversely, patients with very limited time before emergency surgery may not have time for preoperative treatment, though doctors will still manage anemia during and after the operation.

Ideally, anemia screening should occur 6-8 weeks before scheduled heart surgery. Intravenous iron typically begins raising red blood cell counts within 1-2 weeks, with full effects visible in 4-6 weeks. Vitamin B12 and folic acid work over similar timeframes. Red blood cell-stimulating medications may take 2-4 weeks to show effects. Starting treatment as early as possible gives the best chance for blood counts to normalize before surgery, reducing surgical risks.

Frequently Asked Questions

What percentage of heart surgery patients have low blood counts before surgery?

Up to 40% of patients scheduled for heart surgery have anemia (low red blood cell counts) before their operation, according to a 2026 clinical review. This condition increases surgical risks, making preoperative screening and treatment important for better outcomes.

How long before heart surgery should I get tested for anemia?

Doctors recommend anemia screening 6-8 weeks before scheduled heart surgery. This timing allows enough time to treat low blood counts before the operation. If anemia is found, treatment typically takes 4-6 weeks to raise red blood cell levels to safer ranges.

What treatments work best for low blood counts before heart surgery?

Intravenous iron (iron given directly into the bloodstream) works fastest and is preferred when time is limited. Vitamin B12, folic acid, and medications that stimulate red blood cell production are also effective. Combining these treatments in a comprehensive blood management program produces the best results.

Why does anemia before heart surgery cause problems?

Red blood cells carry oxygen throughout your body. During heart surgery, your body needs extra oxygen, but low red blood cell counts mean less oxygen reaches your heart, brain, and other organs. This increases risks of bleeding, infection, and complications during and after surgery.

Can I still have heart surgery if I have anemia?

Yes, but treating anemia before surgery significantly reduces risks. If surgery is urgent and there’s no time for preoperative treatment, doctors will manage anemia during and after the operation. However, preoperative treatment when possible leads to better outcomes and fewer complications.

Want to Apply This Research?

  • Track your hemoglobin and iron levels weekly from the time of screening through surgery. Log the specific numbers (hemoglobin in g/dL, ferritin in ng/mL, iron saturation percentage) to monitor treatment progress. Set a target range with your doctor and watch for steady improvement toward normal values.
  • Set reminders to take iron supplements or attend infusion appointments exactly as scheduled. If taking oral iron, take it with vitamin C (orange juice) to improve absorption, and avoid taking it with coffee or tea. Keep a log of any side effects like nausea or constipation to discuss with your doctor, as adjustments may help.
  • Use the app to track blood test results before surgery, then continue monitoring hemoglobin levels for 4-6 weeks after your operation. Create alerts for scheduled follow-up appointments with your surgeon and primary care doctor. Document any symptoms like unusual fatigue or shortness of breath that might indicate your blood counts are dropping again.

This article reviews clinical best practices for managing anemia before heart surgery based on current medical evidence. It is not a substitute for personalized medical advice from your doctor or surgical team. If you are scheduled for heart surgery, discuss anemia screening and treatment options with your cardiologist or surgeon. Do not start, stop, or change any medications or supplements without consulting your healthcare provider. Individual treatment plans should be based on your specific medical history, current health status, and the type of surgery planned. This information is for educational purposes and should not be used for self-diagnosis or self-treatment.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Management of Preoperative Anemia: Review of Best Practices in Cardiac Surgery. , Innovations (Philadelphia, Pa.) (2026). PubMed 42703183 | DOI
Topics
preoperative anemia heart surgery preparation iron deficiency treatment blood management cardiac surgery risks red blood cell count surgical complications patient blood management program